DrugBank ID stringlengths 7 7 | Accession Numbers stringlengths 7 102 ⌀ | Common name stringlengths 3 226 | CAS stringlengths 7 12 ⌀ | UNII stringlengths 10 10 ⌀ | Synonyms stringlengths 2 1.48k ⌀ | Standard InChI Key stringlengths 27 27 ⌀ |
|---|---|---|---|---|---|---|
DB18994 | null | Remternetug | 2571940-41-3 | A5HTA4J6ME | Remternetug | null |
DB18995 | null | Rademikibart | 2648260-80-2 | NWV8DWU7QM | Rademikibart | null |
DB18996 | null | Povetacicept | 2490217-42-8 | EN2U82XV65 | Povetacicept | null |
DB18997 | null | Plozasiran | 2379776-40-4 | XG9ARL6P25 | Plozasiran | null |
DB18998 | null | Pemvidutide | 2538014-94-5 | A35F525WBG | Pemvidutide | null |
DB18999 | null | Pegtarviliase | 2649372-23-4 | RKK4N4FPA4 | Pegtarviliase | null |
DB19000 | null | Nelmastobart | 2669823-48-5 | 2S69ME4B3R | Nelmastobart | null |
DB19001 | null | Olpasiran | 2225856-03-9 | 8M4GC1EOB4 | ALL-P-AMBO-5'-O-((25S,30S)-39-((2-ACETAMIDO-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)-25,30-BIS((2-(2-((2-ACETAMIDO-2-DEOXY-.BETA.-D-GALACTOPYRANOSYL)OXY)ETHOXY)ETHYL)CARBAMOYL)-1,23,28,33-TETRAOXO-1-SULFANYL-2,5,8,11,14,17,20,37-OCTAOXA-24,29,34-TRIAZA-1.L | null |
DB19002 | null | Narlumosbart | 2646587-68-8 | J38KT46AH8 | Narlumosbart | null |
DB19003 | null | Mivelsiran | 2572991-83-2 | 39CFL75KXH | null | null |
DB19004 | null | BMS-741672 | 1386991-77-0 | 3UAA36FHF1 | N-(5-(ISOPROPYL(METHYL)AMINO)-2-(2-OXO-3-((6-(TRIFLUOROMETHYL)QUINAZOLIN-4-YL)AMINO)PYRROLIDIN-1-YL)CYCLOHEXYL)METHANESULFONAMIDE | PJTGSIKANITYOO-RCOXNQKVSA-N |
DB19005 | null | AGI-134 | 1821461-84-0 | OE0L4ZX3I8 | 2R)-1-((2-(5-((3-(((2R,3R,4R,5S,6R)-5-(((2S,3R,4S,5S,6R)-3,5-DIHYDROXY-6-(HYDROXYMETHYL)-4-(((2R,3R,4S,5R,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL)OXY)OXAN-2-YL)OXY)-3-ACETAMIDO-4-HYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL)OXY)PROPYL)CARBAMOYL) PENTANAMI | ZJYQGJWRGLACDM-UNBAAJOISA-N |
DB19006 | null | Vepdegestrant | 2229711-68-4 | WC1U3R1YMI | 2,6-piperidinedione, 3-(1,3-dihydro-1-oxo-5-(4-((1-(4-((1r,2s)-1,2,3,4-tetrahydro-6-hydroxy-2-phenyl-1-naphthalenyl)phenyl)-4-piperidinyl)methyl)-1-piperazinyl)-2h-isoindol-2-yl)-, (3s)- | TZZDVPMABRWKIZ-XMOGEVODSA-N |
DB19007 | null | BMS-986251 | 2041841-30-7 | 2WQX2MS3MQ | (1R,3S,4R)-4-((3AR,9BR)-9B-((4-FLUOROPHENYL)SULFONYL)-7-(PERFLUOROPROPAN-2-YL)-2,3,3A,4,5,9B-HEXAHYDRO-1H-BENZO(E)INDOLE-3-CARBONYL)-3-METHYLCYCLOHEXANE-1-CARBOXYLIC ACID | JQORWGARJVSRBA-QOTTZFGFSA-N |
DB19008 | null | D3S-001 | 2706637-43-4 | PFW9YLB86H | 2-PIPERAZINEACETONITRILE, 4-(7-(3-AMINO-2-FLUORO-5-METHYL-6-(TRIFLUOROMETHYL)PHENYL)-2-(((2R,7AS)-2-FLUOROTETRAHYDRO-1H-PYRROLIZIN-7A(5H)-YL)METHOXY)-7,8-DIHYDRO-5H-PYRANO(4,3-D)PYRIMIDIN-4-YL)-1-(2-FLUORO-1-OXO-2-PROPEN-1-YL)-, (2S)- | JOLORSRKBHXPFT-PNGHJTAWSA-N |
DB19009 | null | Lunsekimig | 2770858-49-4 | VYR5R5XN5A | Lunsekimig | null |
DB19010 | null | Supinoxin | 888478-45-3 | ZU8OM8V5WF | 1-(3,5-dimethoxyphenyl)-4-((6-fluoro-2-methoxyquinoxalin-3-yl)aminocarbonyl) piperazine | 1-piperazinecarboxamide, 4-(3,5-dimethoxyphenyl)-n-(7-fluoro-3-methoxy-2-quinoxalinyl)- | 4-(3,5-dimethoxyphenyl)-n-(7-fluoro-3-methoxy-quinoxalin-2-yl)piperazine-1-carboxamide | P-p68 inhibitor rx-5902 | KAKPGJJRYRYSTP-UHFFFAOYSA-N |
DB19011 | null | Lepunafusp alfa | 2396411-71-3 | 529C45O9XV | Lepunafusp alfa | null |
DB19012 | null | Efruxifermin | 2375240-92-7 | C1KR8TZ3NE | Immunoglobulin g (synthetic human constant domain fc fragment) fusion protein with fibroblast growth factor 21 (98-arginine,171-glycine,180-glutamic acid) (human mutant clone amg876) | Immunoglobulin g1 (human .gamma.1-chain c-region c-terminal fragment) fusion protein with peptide linker (ggggs)3 fusion protein with f... | null |
DB19013 | null | Insulin efsitora alfa | 2131038-11-2 | OZ465SMQ28 | Insulin efsitora alfa | null |
DB19014 | null | Imdusiran | 2839476-19-4 | 256UZ34AF2 | Imdusiran | null |
DB19015 | null | Forimtamig | 2649379-96-2 | 1GK8Z1OT1R | Forimtamig | null |
DB19016 | null | Equecabtagene autoleucel | null | null | autologous T lymphocytes obtained from peripheral blood mononuclear cells by leukapheresis, transduced with a self-inactivating, non-replicating lentiviral vector encoding a chimeric antigen receptor (CAR) targeting human B cell maturation antigen (BCMA) | Eque-cel | Equecabtagene autoleucel | null |
DB19017 | null | Eltrekibart | 2484883-56-7 | WB62WIH13E | Eltrekibart | null |
DB19018 | null | Elebsiran | 2648009-64-5 | W982Y6N4X7 | Elebsiran | null |
DB19019 | null | Ecnoglutide | 2459531-73-6 | KM6YM7L8LH | Ecnoglutide | null |
DB19020 | null | Bovhyaluronidase azoximer | 1383710-57-3 | 43VB0F6WF9 | Bovhyaluronidase azoximer | null |
DB19021 | null | Bevonescein | 2276787-79-0 | 5RG113V7K3 | Bevonescein | null |
DB19022 | null | L-377202 | 207395-85-5 | VDXVABRQTV | 5-((2s,4r)-2-(((1s)-2-(((1s)-2-(((1s)-2-(((1s)-4-amino-1-(((1s)-1-(hydroxymethyl)-2-(((1s)-1-(((2s,3s,4s,6r)-3-hydroxy-2-methyl-6-(((1s,3s)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1h-tetracen-1-yl)oxy)tetrahydropyran-4-yl) | 5,12-NAPHTHACENEDIONE, 10-((3-(((4R)-1-(4-CARBOXY-1-OXOBUTYL)-4... | CZXGBIFEWYVYJY-NPLULESDSA-N |
DB19023 | null | Chiglitazar | 743438-45-1 | E6EJV1J6Y0 | (2s)-3-(4-(2-carbazol-9-ylethoxy)phenyl)-2-(2-(4-fluorobenzoyl)anilino)propanoic acid | Carfloglitazar, (s)- | L-tyrosine, o-(2-(9h-carbazol-9-yl)ethyl)-n-(2-(4-fluorobenzoyl)phenyl)- | O-(2-(9h-carbazol-9-yl)ethyl)-n-(2-(4-fluorobenzoyl)phenyl)-l-tyrosine | QNLWMPLUWMWDMQ-YTTGMZPUSA-N |
DB19024 | null | DA-8031 | 1148027-74-0 | VN9EXL272Y | 1-(3-(DIMETHYLAMINO)PROPYL)-1,3-DIHYDRO-1-(4-METHOXYPHENYL)-5-ISOBENZOFURANCARBONITRILE | 5-ISOBENZOFURANCARBONITRILE, 1-(3-(DIMETHYLAMINO)PROPYL)-1,3-DIHYDRO-1-(4-METHOXYPHENYL)- | ISOBENZOFURANCARBONITRILE | RCMIUWUYNFSCAE-UHFFFAOYSA-N |
DB19025 | null | Dazodalibep | 2245953-10-8 | HN5US76BWF | PROTEIN VIB4920 (RECOMBINANT HUMAN TENASCIN C CD40 LIGAND-BINDING THIRD FIBRONECTIN TYPE III DOMAIN) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC 19-AMINO ACID LINKER) FUSION PROTEIN WITH TENASCIN C CD40 LIGAND-BINDING THIRD FIBRONECTIN TYPE III DOMAIN (HUMAN | null |
DB19026 | null | .gamma.-brain natriuretic peptide | 114471-18-0 | 07Y2V56IUP | Brain natriuretic peptide | Natriuretic peptides b | Natriuretic peptides b (human) | null |
DB19027 | null | Arterolane | 664338-39-0 | 3N1TN351VB | Dispiro(cyclohexane-1,3'-(1,2,4)trioxolane-5',2''-tricyclo(3.3.1.13,7)decane)-4-acetamide, n-(2-amino-2-methylpropyl)-, cis- | VXYZBLXGCYNIHP-ACBWXVLLSA-N |
DB19028 | null | Atamparib | 2381037-82-5 | B1MW2ME77A | 3(2h)-pyridazinone, 5-(((1s)-1-methyl-2-(3-oxo-3-(4-(5-(trifluoromethyl)-2-pyrimidinyl)-1-piperazinyl)propoxy)ethyl)amino)-4-(trifluoromethyl)- | 5-(((2s)-1-(3-oxo-3-(4-(5-(trifluoromethyl)pyrimidin-2- yl)piperazin-1-yl)propoxy)propan-2-yl)amino)-4- (trifluoromethyl)pyridazin-3(2h)-one | UQZCQKXJAXKZQH-LBPRGKRZSA-N |
DB19029 | null | Atuliflapon | 2041075-86-7 | NV6352Y6TV | (1r,2r)-2-(4-(3-methyl-1h-pyrazol-5-yl)benzoyl)-n-(4-oxo-6,7-dihydro-5h-pyrazolo(1,5-a)pyrazine-3-yl)cyclohexanecarboxamide | Cyclohexanecarboxamide, 2-(4-(5-methyl-1h-pyrazol-3-yl)benzoyl)-n-(4,5,6,7-tetrahydro-4-oxopyrazolo(1,5-a)pyrazin-3-yl)-, (1r,2r)- | ROTWSDMXHVGAHZ-QZTJIDSGSA-N |
DB19030 | null | Atuzaginstat | 2211981-76-7 | DGN7ROZ8EN | Cyclopentanecarboxamide, n-((1s)-5-amino-1-(2-(2,3,6-trifluorophenoxy)acetyl)pentyl)- | N-((3s)-7-amino-2-oxo-1-(2,3,6- trifluorophenoxy)heptan-3-yl)cyclopentanecarboxamide | OLIMBXKACVCIMM-HNNXBMFYSA-N |
DB19031 | null | Azafenidin | 68049-83-2 | XQK9668H5M | 2-(2,4-dichloro-5-(2-propynyloxy)phenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-a)pyridin-3(2h)-one | 2-(2,4-dichloro-5-prop-2-ynyloxyphenyl)-5,6,7,8-tetrahydro-1,2,4-triazolo(4,3-a)pyridin-3(2h)-one | Evolus | Milestone | XOEMATDHVZOBSG-UHFFFAOYSA-N |
DB19032 | null | Bavdegalutamide | 2222112-77-6 | H6NYM0V650 | 3-pyridazinecarboxamide, n-(trans-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-((4-(2-(2,6-dioxo-3-piperidinyl)-6-fluoro-2,3-dihydro-1,3-dioxo-1h-isoindol-5-yl)-1-piperazinyl)methyl)-1-piperidinyl)- | Arv-110 (protac) | N-((1r,4r)-4-(3-chloro-4-cyanophenoxy)cyclohexyl)-6-(4-((4-(2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1,3-... | CLCTZVRHDOAUGJ-SYVGMNBRSA-N |
DB19033 | null | Befiradol | 208110-64-9 | RAT9OHA1YH | (2E)-2-butenedioate | (3-chloro-4-fluorophenyl)(4-fluoro-4-((((5-methylpyridin-2-yl)methyl)amino)methyl)piperidin-1-yl)methanone | 4-piperidinemethanamine | PKZXLMVXBZICTF-UHFFFAOYSA-N |
DB19034 | null | Mevidalen | 1638667-79-4 | 4A3702A96F | 2-(2,6-dichlorophenyl)-1-((1s,3r)-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-3,4-dihydroisoquinolin-2(1h)-yl)ethanone | Ethanone, 2-(2,6-dichlorophenyl)-1-((1s,3r)-3,4-dihydro-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-2(1h)-isoquinolinyl)- | XHCSBQBBGNQINS-DOTOQJQBSA-N |
DB19035 | null | Bersacapavir | 1638266-40-6 | 2456KW2166 | 1h-pyrrole-2-carboxamide, n-(3-cyano-4-fluorophenyl)-1-methyl-4-((((1s)-2,2,2-trifluoro-1-methylethyl)amino)sulfonyl)- | N-(3-cyano-4-fluorophenyl)-1-methyl-4-(((2s)-1,1,1-trifluoro-2-propanyl)sulfamoyl)-1hpyrrole-2-carboxamide | SBVBIDUKSBJYEF-VIFPVBQESA-N |
DB19036 | null | Mizagliflozin | 666843-10-3 | 1X96A704XV | 3-((3-(4-((3-(.beta.-d-glucopyranosyloxy)-5-(propan-2-yl)-1h-pyrazol-4-yl)methyl)-3-methylphenoxy)propyl)amino)-2,2-dimethylpropanamide | Propanamide, 3-((3-(4-((3-(.beta.-d-glucopyranosyloxy)-5-(1-methylethyl)-1h-pyrazol-4-yl)methyl)-3-methylphenoxy)propyl)amino)-2,2-dimethyl- | LREHMKLEOJAVMQ-TXKDOCKMSA-N |
DB19037 | null | Cofirasersen | 2247669-96-9 | XV92IM2BG0 | Dna, d(p-thio)((2'-o,4'-c-((s)-ethylidene))m5rc-(2'-o,4'-c-((s)-ethylidene))m5rc-(2'-o,4'-c-((s)-ethylidene))m5rc-g-a-t-a-g-m5c-t-g-g-t-(2'-o,4'-c-((s)-ethylidene))m5ru-(2'-o,4'-c-((s)-ethylidene))rg-(2'-o,4'-c-((s)-ethylidene))m5ru) | DNA, D(P-THIO)((2',5'-ANHYDRO-6'-DEOXY-4'-C-(HYDROXYMETHYL)-.ALPHA.-L-MANNOFURANO)M5... | null |
DB19038 | null | Narazaciclib | 1357470-29-1 | QJ8RO3296G | Pyrido(2,3-d)pyrimidine-6-carbonitrile, 8-cyclopentyl-7,8-dihydro-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-7-oxo- | VADOZMZXXRBXNY-UHFFFAOYSA-N |
DB19039 | null | Navocaftor | 2159103-66-7 | W2F2XU189O | (5-(3-amino-5-((4-(trifluoromethoxy)phenyl)sulfonyl)pyridin-2-yl)-1,3,4-oxadiazol-2-yl)methanol | 1,3,4-oxadiazole-2-methanol, 5-(3-amino-5-((4-(trifluoromethoxy)phenyl)sulfonyl)-2-pyridinyl)- | WOXOLLSAICIZNO-UHFFFAOYSA-N |
DB19040 | null | Nelonicline | 1026134-63-3 | WX8LOM674D | 2-((3r,4s,5s,7s)-1-azaadamantan-4-yloxy)-5-phenyl-1,3,4-thiadiazole, rel- | QZDCYUCETTWCMO-WTGKZIDZSA-N |
DB19041 | null | Elimusertib | 1876467-74-1 | 7N13IK9LNH | 1,7-naphthyridine, 2-((3r)-3-methyl-4-morpholinyl)-4-(1-methyl-1h-pyrazol-5-yl)-8-(1h-pyrazol-3-yl)- | YBXRSCXGRPSTMW-CYBMUJFWSA-N |
DB19042 | null | Orismilast | 1353546-86-7 | JH1CX8SG5V | 2-(3,5-dichloro-1-oxido-4-pyridinyl)-1-(7-(difluoromethoxy)-2',3',5',6'-tetrahydro-1',1'-dioxidospiro(1,3-benzodioxole-2,4'-(4h)thiopyran)-4-yl)ethanone | ZININGNRPUGNSL-UHFFFAOYSA-N |
DB19043 | null | Imlunestrant | 2408840-26-4 | 9CXQ3PF69U | (5r)-5-(4-(2-(3-(fluoromethyl)azetidin-1-yl)ethoxy)phenyl)-8-(trifluoromethyl)-5h-(1)benzopyrano(4,3-c)quinolin-2-ol | 5h-(1)benzopyrano(4,3-c)quinolin-2-ol, 5-(4-(2-(3-(fluoromethyl)-1-azetidinyl)ethoxy)phenyl)-8-(trifluoromethyl)-, (5r)- | UVBQMXOKKDCBJN-MUUNZHRXSA-N |
DB19044 | null | Irsenontrine | 1429509-82-9 | 54QB00NNRB | 4h-pyrazolo(4,3-c)quinolin-4-one, 1,5-dihydro-7-(2-methoxy-3,5-dimethyl-4- pyridinyl)-1-((3s)-tetrahydro-3-furanyl)- | 7-(2-methoxy-3,5-dimethylpyridin-4-yl)-1-((3s)-tetrahydrofuran-3-yl)-1,5-dihydro-4h-pyrazolo(4,3-c)quinolin-4-one | CKJDCNZBABIEBZ-HNNXBMFYSA-N |
DB19045 | null | Lartesertib | 2495096-26-7 | KL7B6D38VC | 2H-Imidazo[4,5-c]quinolin-2-one, 8-(1,3-dimethyl-1H-pyrazol-4-yl)-1-(3-fluoro-5-methoxy-4-pyridinyl)-1,3-dihydro-7-methoxy-3-methyl-, (1S)- | 8-(1,3-dimethyl-1h-pyrazol-4-yl)-1-(3-fluoro-5-methoxy-4-pyridinyl)-1,3-dihydro-7-methoxy-3-methyl-2h-imidazo(4,5-c)quinolin-2-one | WNEFOSMCGCLLJU-UHFFFAOYSA-N |
DB19046 | null | Lazuvapagon | 2379889-71-9 | CK6VS66Q6X | (4s)-n-((2s)-1-hydroxypropan-2-yl)-methyl-1-(2-methyl-4-(3-methyl-1h-pyrazol-1-yl)benzoyl)-2,3,4,5-tetrahydro-1h-1-benzazepine-4-carboxamide | 1h-1-benzazepine-4-carboxamide, 2,3,4,5-tetrahydro-n-((1s)-2-hydroxy-1-methylethyl)-4-methyl-1-(2-methyl-4-(3-methyl-1h-pyrazol-1-yl)benzoyl)-, (4s)- | BKHSWGKGWGWMSM-CCLHPLFOSA-N |
DB19047 | null | Leflutrozole | 143030-47-1 | RCX0IE6EJZ | 4,4'-(fluoro-1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile | PZDLRBUQYWMNBR-UHFFFAOYSA-N |
DB19048 | null | BNC-210 | 1020634-41-6 | QP49AY37OY | 1,8-NAPHTHYRIDIN-4(1H)-ONE, 6-((2,3-DIHYDRO-1H-INDEN-2-YL)AMINO)-1-ETHYL-3-(4-MORPHOLINYLCARBONYL)- | 6-((2,3-dihydro-1h-inden-2-yl)amino)-1-ethyl-3-(4-morpholinylcarbonyl)-1,8-naphthyridin-4(1h)-one | ZAEIHDZLLJCJFP-UHFFFAOYSA-N |
DB19049 | null | IP-2018 | 881387-68-4 | 60XT58V8NZ | 2h-1-benzopyran-2-one, 7-((3-exo)-8-azabicyclo(3.2.1)oct-3-yloxy)- | 7-((3-exo)-8-azabicyclo(3.2.1)oct-3-yloxy)-2h-1-benzopyran-2-one | PGUDASZQLOAZRX-DABQJJPHSA-N |
DB19050 | null | Bemnifosbuvir | 1998705-64-8 | 7UM3SQL968 | (s)-isopropyl 2-((s)-(((2r,3r,4r,5r)-5-(2-amino-6-(methylamino)-9h-purin-9-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphorylamino)propanoate | At-527 free base | L-alanine, n-((p(s),2'r)-2-amino-2'-deoxy-2'-fluoro-n,2'-dimethyl-p-phenyl-5'-adenylyl)-, 1-methylethyl ester | N-((p(s),2'r)-2-... | OISLSHLAXHALQZ-LZEIJKKFSA-N |
DB19051 | null | Zandatrigine | 2154406-04-7 | SV2WPA4R4J | Benzenesulfonamide, 2-fluoro-5-methyl-4-(methyl((3s)-1-(phenylmethyl)-3-pyrrolidinyl)amino)-n-4-thiazolyl- | UCSHINHOAVARGQ-SFHVURJKSA-N |
DB19052 | null | CH-1504 L-isomer | 227016-66-2 | 86T288K8BS | (2s)-2-((4-(2-(2,4-diaminoquinazolin-6-yl)ethyl)benzoyl)amino)-4-methylene-pentanedioic acid | 4-methylene-n-(4-(2-(2,4-diaminoquinazolin-6-yl)ethyl)benzoyl)-l-glutamic acid | L-glutamic acid, n-(4-(2-(2,4-diamino-6-quinazolinyl)ethyl)benzoyl)-4-methylene- | L-m-trex | L-mobiletrex | NAWXUBYGYWOOIX-SFHVURJKSA-N |
DB19053 | null | Udifitimod | 1883345-06-9 | 283FTA936D | ((1R,3S)-1-amino-3-((S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol | [(1R,3S)-1-amino-3-{(6S)-6-[2-(2-methoxyphenyl)ethyl]- 5,6,7,8-tetrahydronaphthalen-2-yl}cyclopentyl]methanol | Cyclopentanemethanol, 1-amino-3-((6s)-5,6,7,8-tetrahydro-6-(2-(2-methoxyphenyl)ethyl)-2-naphthalenyl)-, ... | QCMHGCDOZLWPOT-FMNCTDSISA-N |
DB19054 | null | Deudextromethorphan | 1079043-55-2 | 427476LZFT | (+)-3-d3-methoxy-17-d3-methyl-(9.alpha.,13.alpha.,14.alpha.)-morphinan | D6-dextromethorphan | Dextromethorphan d6 | Morphinan, 3-(methoxy-d3)-17-(methyl-d3)-, (9.alpha.,13.alpha.,14.alpha.)- | MKXZASYAUGDDCJ-QNNIAVNKSA-N |
DB19055 | null | Deudomperidone | 2121525-08-2 | HN0VIB0W8W | 2h-benzimidazol-2-one-4,5,6,7-d4, 1-(3-(4-(5-chloro-2,3-dihydro-2-oxo-1h-benzimidazol-1-yl)-1-piperidinyl)propyl)-1,3-dihydro- | 3-(3-(4-(5-chloro-2-oxo-3hbenzimidazol-1-yl)-1- piperidyl)propyl)-4,5,6,7- tetradeutero-1h-benzimidazol-2- one | FGXWKSZFVQUSTL-GYABSUSNSA-N |
DB19056 | null | Deupirfenidone | 1093951-85-9 | 1QC36BHI6S | 1-phenyl-5-(trideuteriomethyl)-1,2-dihydropyridin-2-one | 2(1h)-pyridinone, 5-(methyl-d3)-1-phenyl- | ISWRGOKTTBVCFA-FIBGUPNXSA-N |
DB19057 | null | Deutarserine | 103292-62-2 | OD54L0MH86 | D-serine-2-d | MTCFGRXMJLQNBG-LIIDHCAMSA-N |
DB19058 | null | Iclepertin | 1421936-85-7 | M43ZDU10DD | [5-(Methylsulfonyl)-2-[(1R)-2,2,2-trifluoro-1-methylethoxy]phenyl][(1R,5R)-1-[5-(trifluoromethyl)-3-isoxazolyl]-3-azabicyclo[3.1.0]hex-3-yl]methanone | Methanone, (5-(methylsulfonyl)-2-((1r)-2,2,2-trifluoro-1-methylethoxy)phenyl)((1r,5r)-1-(5-(trifluoromethyl)-3-isoxazolyl)-3-azabicyclo(3.1.0)hex-3-yl)- | MYHDQTVHHMSLEF-DDBGAENHSA-N |
DB19059 | null | Iltamiocel | null | QTA2A5N6BE | AMDC | AMDC-USR | COOK MYOSITES AUTOLOGOUS MUSCLE DERIVED CELLS (AMDC) ARE EXPANDED (AMPLIFIED) THROUGH A TWO-PHASE MANUFACTURING PROCESS. THE EXPANSION IS CONSISTENT WITH ROUTINE CELL CULTURE PRACTICES FOR ADHERENT CELLS. DURING ADHERENT CELL CULTURE EXPANSION, CELLS REP | null |
DB19060 | null | Lomvastomig | 2648840-52-0 | 9GAH9VG7IP | Anti-pd-1/tim-3 bispecific antibody ro7121661 | null |
DB19061 | null | Nezastomig | 2657613-60-8 | M355PGI1TG | Anti-psma/cd28 bispecific antibody regn5678 | null |
DB19062 | null | Pegozafermin | 2489589-60-6 | UO870O6MFS | Bio89-100 (long-acting glycopegylated fibroblast growth factor 21 (fgf21) analogue) | null |
DB19063 | null | Erzotabart | 2430792-01-9 | 1I9AVY2IS7 | gamma1 heavy chain Homo sapiens (1-450) [VH (Homo sapiens IGHV1-69*04 (93.8%) -(IGHD) -IGHJ3*02 (93.8%), CDR-IMGT [8.8.14] (26-33.51-58.97-110)) (1-121)-Homo sapiens IGHG1*03, G1m3, nG1m1 CH1 R120 CH3 E12, M14, IGHG1v34 CH3 G109 (CH1 R120 (218) (122-219) | Immunoglobulin g1 (434-glycine), anti-(human cd38 antigen) (hum... | null |
DB19064 | null | Danburstotug | 2307144-65-4 | F44C4N45HG | Immunoglobulin g1, anti-(human programmed death-ligand 1) (human monoclonal sti-3031 .gamma.1-chain), disulfide with human monoclonal sti-3031 .lambda.-chain, dimer | null |
DB19065 | null | Renvistobart | 2725062-35-9 | 81J55YFQ16 | Anti-TIGIT Monoclonal Antibody BMS-986207 | null |
DB19066 | null | Belrestotug | 2574438-65-4 | 59HAW3EQ4C | CLONE 31282 | Immunoglobulin g1, anti-(human receptor tigit) (human monoclonal eos884448 .gamma.1-chain), disulfide with human monoclonal eos884448 .kappa.-chain, dimer | null |
DB19067 | null | VIS-410 | 2043950-09-8 | 14WE3Z92C4 | IMMUNOGLOBULIN G1, ANTI-(INFLUENZA HEMAGGLUTININ) (HUMAN MONOCLONAL VIS410 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VIS410 .KAPPA.-CHAIN, DIMER | null |
DB19068 | null | IMT-288 | 637771-94-9 | ECC868Y9YT | (4R)-5-(((1R)-1-CARBAMOYL-5-((2-((4-(2-(1H-IMIDAZOL-5-YL)ETHYLAMINO)-4-OXO-BUTANOYL)AMINO)ACETYL)AMINO)PENTYL)AMINO)-4-(((2R)-2-(((2R)-3-(4-HYDROXYPHENYL)-2-((2-(4,7,10-TRIS(CARBOXYMETHYL)-1,4,7,10-TETRAZACYCLODODEC-1-YL)ACETYL)AMINO)PROPANOYL)AMINO)-6-( | D-LYSINAMIDE, N-((4,7,10-TRIS(CARBOXYMETHYL)-1,4,7,10-TETRAAZAC... | AUULGUVUMUKNPY-OGBYROOVSA-N |
DB19069 | null | Becotatug | 2648260-93-7 | 981YA69AO3 | Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-Mus musculus monoclonal JMT101 γ1-chain), disulfide with human-Mus musculus monoclonal JMT101 κ-chain, dimer | Jmt101 (fully human monoclonal igg1 antibody targeting epidermal growth factor receptor (egfr)) | null |
DB19070 | null | Aklavine | 66676-88-8 | T87WN25BNW | 1-naphthacenecarboxylic acid, 2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-((2,3,6-trideoxy-3-(dimethylamino)-.alpha.-l-lyxo-hexopyranosyl)oxy)-, methyl ester, (1r,2r,4s)- | Aclacinomycin | Aclacinomycin t | LJZPVWKMAYDYAS-QKKPTTNWSA-N |
DB19071 | null | Lerodalcibep | 2250073-78-8 | 1PHP3QG5PZ | Engineered binding protein (1-96) anti-(human proprotein convertase subtilisin/kexin type 9), derived from human tenth fibronectin type iii domain, fused via peptidyl linker (97gsgsgs102) to human serum albumin (103-687), variant (c34>a136) | Protein lib003 (recombinant human proprotein convertase subtilisin/kexin type... | null |
DB19072 | null | Letolizumab | 1450981-87-9 | 449MIE2SD6 | Immunoglobulin (synthetic light chain variable region fragment) fusion protein with immunoglobulin g (synthetic fc fragment), noncovalently linked dimer | null |
DB19073 | null | Levotofisopam | 82059-51-6 | 11ZYL7QK34 | (-)-(5s)-1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5h-2,3-benzodiazepine | (s)-tofisopam | 5h-2,3-benzodiazepine, 1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl, (5s)- | RUJBDQSFYCKFAA-OAHLLOKOSA-N |
DB19074 | null | Ligustrazine | 1124-11-4 | V80F4IA5XG | 2,3,5,6-tetramethylpyrazine | Chuanxingzine | Chuanxiongqin | Ligustrazin | Pyrazine, 2,3,5,6-tetramethyl- | Pyrazine, tetramethyl- | Tetramethylpyrazine | Tetrapyrazine | FINHMKGKINIASC-UHFFFAOYSA-N |
DB19075 | null | KRN-330 | null | A64J777I28 | ANTI-A33 FULLY-HUMAN MONOCLONAL ANTIBODY | HUMAN MONOCLONAL ANTIBODY TO COLON CANCER ANTIGEN A33 | null |
DB19076 | null | Lilotomab | 1453362-55-4 | 58I6YNR7BV | Immunoglobulin g1, anti-(human cd antigen cd37) (mus musculus monoclonal hh1 heavy chain), disulfide with mus musculus monoclonal hh1 light chain, dimer | null |
DB19077 | null | Aminoflavone | 165179-35-1 | 2EXS38428U | 4h-1-benzopyran-4-one, 5-amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-7-methyl- | 5-amino-2-(4-amino-3-fluorophenyl)-6,8-difluoro-7-methyl-4h-1-benzopyran-4-one | RTUZVPPGTJRELI-UHFFFAOYSA-N |
DB19078 | null | Ensovibep | 2451126-06-8 | PV6AA88RDU | Designed ankyrin repeat protein (synthetic bivalent human albumin-binding) fusion protein with designed ankyrin repeat protein (synthetic trivalent severe acute respiratory syndrome coronavirus 2 spike glycoprotein receptor binding domain-binding) | null |
DB19079 | null | Fepixnebart | 1799706-87-8 | FP2PL0HRK8 | IMMUNOGLOBULIN G4 (226-PROLINE,232-ALANINE,233-ALANINE,DE-C-TERMINAL-LYSINE), ANTI-(HUMAN EPIREGULIN AND TRANSFORMING GROWTH FACTOR .ALPHA.) (HUMAN-MUS MUSCULUS MONOCLONAL LY3016859 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LY3016859 | Ly3016859 (humanized monoclonal antibody to human tgf.alpha. and... | null |
DB19080 | null | Freneslerbart | 2453195-94-1 | AL6PH7LX2Y | Anti-cat allergen fel d 1 monoclonal anitbody regn-1908 | Immunoglobulin G4 [227-proline], anti-(Felis catus allergen Fel d1) (human monoclonal REGN1908 γ4-chain), disulfide with human monoclonal REGN1908 κ-chain, dimer | null |
DB19081 | null | Izokibep | 2226130-02-3 | 8B8VV1W6FZ | Affibody aby-035 (recombinant human interleukin 17a-binding) | FUSION PROTEIN COMPOSED OF 3 BINDING DOMAINS CONSISTING OF THREE-ALPHA-HELIX MOTIFS, EACH DERIVED FROM THE IMMUNOGLOBULIN (IG)-BINDING Z-DOMAIN OF STAPHYLOCOCCAL PROTEIN A (SPA), ENGINEERED FOR BINDING TO TWO HOMODIMER SUBUNITS OF HUMAN INTERLEUKIN 17A ( | null |
DB19082 | null | Botulinum Toxin Type E | null | T579M564JY | BONTOXILYSIN-E | BOTULINUM NEUROTOXIN SEROTYPE E (BONT/E) (EB-001) | BOTULINUM NEUROTOXIN TYPE E | null |
DB19083 | null | Mescaline | 54-04-6 | RHO99102VC | 2-(3,4,5-trimethoxyphenyl)ethanamine | 3,4,5-trimethoxyphenethylamine | RHCSKNNOAZULRK-UHFFFAOYSA-N |
DB19084 | null | Metacavir | 120503-45-9 | W5EOS3V193 | ((2s,5r)-5-(2-amino-6-methoxy-purin-9-yl)tetrahydrofuran-2-yl)methanol | 2',3'-dideoxy-6-o-methylguanosine | Guanosine, 2',3'-dideoxy-6-o-methyl- | FJAOCNGVPLTSLD-NKWVEPMBSA-N |
DB19085 | null | Novolimus | 151519-50-5 | 2719UAHUA8 | 16-o-demethylrapamycin | 16-o-demethylsirolimus | 7-o-demethylrapamycin | 7-o-demethylsirolimus | Rapamycin, 7-o-demethyl- | ZHYGVVKSAGDVDY-QQQXYHJWSA-N |
DB19086 | null | Oridonin | 28957-04-2 | 0APJ98UCLQ | Isodonol | Kaur-16-en-15-one, 7,20-epoxy-1,6,7,14-tetrahydroxy-, (1.alpha.,6.beta.,7.alpha.,14r)- | Kaur-16-en-15-one, 7.alpha.,20-epoxy-1.alpha.,6.beta.,7,14-tetrahydroxy-, (14r)- | Oridonine | Pure oridonin | SDHTXBWLVGWJFT-XKCURVIJSA-N |
DB19087 | null | Shigella sonnei strain 53G | null | 3JU3LM3632 | null | null |
DB19088 | null | Asundexian | 2064121-65-7 | LA585UM8DE | 1(2h)-pyridineacetamide, n-(4-(aminocarbonyl)-3-fluorophenyl)-4-(5-chloro-2-(4-(trifluoromethyl)-1h-1,2,3-triazol-1-yl)phenyl)-.alpha.-ethyl-5-methoxy-2-oxo-, (.alpha.s)- | XYWIPYBIIRTJMM-IBGZPJMESA-N |
DB19089 | null | Propionibacterium acnes | null | TRZ1AA965O | Bacillus acnes | null |
DB19090 | null | Baxdrostat | 1428652-17-8 | NF3P9Z8J5Y | (+)-(r)-n-(4-(1-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-6-yl)-5,6,7,8-tetrahydroisoquinolin-8-yl)propionamide | N-((8r)-5,6,7,8-tetrahydro-4-(1,2,3,4-tetrahydro-1-methyl-2-oxo-6-quinolinyl)-8-isoquinolinyl)propanamide | Propanamide, n-((8r)-5,6,7,8-tetrahydro-4-(1,2,3,4-tetrahydro-1-methyl-2-oxo-6-quinolinyl)-8-isoquin... | VDEUDSRUMNAXJG-LJQANCHMSA-N |
DB19091 | null | Bleomycin A2 | 11116-31-7 | 13M89UEA7W | Bleogin | Bleomycinamide, n1-(3-(dimethylsulfonio)propyl)- | Pingyangmycin a2 | Zhengguangmycin a2 | OYVAGSVQBOHSSS-UAPAGMARSA-N |
DB19092 | null | Modified vaccinia virus Ankara-85A antigen | 2171576-44-4 | H0QZ75H2XY | Modified vaccinia virus ankara-mycolyl transferase 85a (mycobacterium tuberculosis h37rv) expressing virus | null |
DB19093 | null | Lactobacillus crispatus strain CTV-05 | null | RP8X0ZB061 | Lactin-V | Lactobacillus crispatus (CTV-05) | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.